Di Yan

Di Yan

Auto-generated profile, based on publicly available information

Di Yan

Department of Pathology University of Wisconsin Madison Wisconsin USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Science Immunology
Verified
Journal Article
Closed access
RCRochelle L. Castillo
Rochelle L. Castillo
ISIkjot Sidhu
Ikjot Sidhu
IDIgor Dolgalev
Igor Dolgalev
TCTinyi Chu
Tinyi Chu
APAleksandr Prystupa
Aleksandr Prystupa
SNShruti Naik
Shruti Naik
Whereas the cellular and molecular features of human inflammatory skin diseases are well characterized, their tissue context and systemic impact remain poorly understood. We thus profiled human psoriasis (PsO) as a prototypic immune-mediated condition with a high predilection for extracutaneous involvement. Spatial transcriptomics (ST) analyses of 25 healthy, active lesion, and clinically uninvolved skin biopsies and integration with public single-cell transcriptomics data revealed marked differences in immune microniches between healthy and inflamed skin. Tissue-scale cartography further identified core disease features across all active lesions, including the emergence of an inflamed suprabasal epidermal state and the presence of B lymphocytes in lesional skin. Both lesional and distal nonlesional samples were stratified by skin disease severity and not by the presence of systemic disease. This segregation was driven by macrophage-, fibroblast-, and lymphatic-enriched spatial regions with gene signatures associated with metabolic dysfunction. Together, these findings suggest that mild and severe forms of PsO have distinct molecular features and that severe PsO may profoundly alter the cellular and metabolic composition of distal unaffected skin sites. In addition, our study provides a valuable resource for the research community to study spatial gene organization of healthy and inflamed human skin.

1 September 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
DYDi Yan
Di Yan
JGJohann Gudjonsson
Johann Gudjonsson
SLStephanie Le
Stephanie Le
EMEmanual Maverakis
Emanual Maverakis
OPOlesya Plazyo
Olesya Plazyo
WLWilson Liao
Wilson Liao
Psoriasis is a chronic inflammatory condition characterized by systemic immune dysregulation. Over the past several years, advances in genetics, microbiology, immunology, and mouse models have revealed the complex interplay between the heritable and microenvironmental factors that drive the development of psoriatic inflammation. In the first of this two-part review series, the authors will discuss the newest insights into the pathogenesis of psoriatic disease and highlight how the evolution of these scientific fields has paved the way for a more personalized approach to psoriatic disease treatment.

1 October 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
DYDi Yan
Di Yan
ABAndrew Blauvelt
Andrew Blauvelt
ADAmit K. Dey
Amit K. Dey
RGRachel S. Golpanian
Rachel S. Golpanian
SHSamuel T. Hwang
Samuel T. Hwang
WLWilson Liao
Wilson Liao
Although psoriasis and psoriatic arthritis (PsA) have been classically considered to be diseases of the skin and joints, respectively, emerging evidence suggests that a combination of innate and environmental factors creates widespread immune dysfunction, affecting multiple organ systems. A greater understanding of the pathogenesis of psoriasis and the systemic effects of psoriatic inflammation has allowed for the development of new, more effective treatments. The second portion of this two-part review series examines the comorbidities associated with psoriasis and PsA as well as the most recent advances in targeted systemic therapies for these conditions.

10 March 2022 in JID Innovations
Verified
Journal Article
Open access
HCHsin-Wen Chang
Hsin-Wen Chang
DYDi Yan
Di Yan
RSRasnik Singh
Rasnik Singh
ABAudrey Bui
Audrey Bui
KLKristina Lee
Kristina Lee
WLWilson Liao
Wilson Liao
Psoriasis is a chronic, inflammatory skin disease that affects 2‒3% of the global population. Besides skin manifestations, patients with psoriasis have increased susceptibility to a number of comorbidities, including psoriatic arthritis, cardiovascular disease, and inflammatory bowel disease. To understand the systemic component of psoriasis pathogenesis, we performed a pilot study to examine the fecal metagenome, host colonic transcriptome, and host peripheral blood immune profiles of patients with psoriasis and healthy controls. Our study showed increased functional diversity in the gut microbiome of patients with psoriasis. In addition, we identified microbial species that preferentially associate with patients with psoriasis and which have been previously found to associate with other autoimmune diseases. Intriguingly, our data revealed three psoriasis subgroups that have distinct microbial and host features. Integrating these features revealed host‒microbe associations that are specific to psoriasis or particular psoriasis subgroups. Our findings provide insight into the factors that may affect the development of comorbidities in patients with psoriasis and may hold diagnostic potential for early identification of patients with psoriasis at risk for these comorbidities.

5 June 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CMChitrasen Mohanty
Chitrasen Mohanty
CSChandra Singh
Chandra Singh
JDJoseph A. Daccache
Joseph A. Daccache
WDWilliam Damsky
William Damsky
CKChristina Kendziorski
Christina Kendziorski
BSBridget E. Shields
Bridget E. Shields

28 June 2025 in Wound Repair and Regeneration
Verified
Journal Article
Open access
MJMary Junak
Mary Junak
PKParth Khatri
Parth Khatri
JZJocelyn Zajac
Jocelyn Zajac
PKPhillip Kubica
Phillip Kubica
DYDi Yan
Di Yan
AGAngela Gibson
Angela Gibson
Histologic analyses of burn tissue are unable to discern reversible injury. Advanced molecular profiling, such as bulk RNA‐sequencing, provides more detail; however, these methods lose spatial context. Spatial transcriptomics allows gene transcripts to be mapped to tissue locations, revealing the molecular pathways activated in the burn tissue microenvironment, where the depth of injury guides prognosis. This work demonstrates the capability of spatial transcriptomics to detect spatial gene expression patterns in burn tissue. Specifically, we show that (i) spatially variable expressed genes are distinct across different burn depth regions, which would not be identified with bulk RNA‐sequencing, (ii) transcriptionally distinct burn tissue regions are defined by gene signatures associated with diverse cell types and biological pathways, and (iii) these spatial gene signatures are identified in a subset of previously published bulk samples, suggesting their potential application in large‐scale and integrated studies. Caveats of this technology in burn tissue are provided to guide future research. This study highlights the promise of spatial transcriptomics to understand the human burn wound microenvironment and identify specific regions with regenerative potential that can be the target of tailored therapeutics, providing an alternative to imprecise excision and skin grafting.